Walden Catalyst Venture

Walden Catalyst is an early-stage venture capital firm focused on deep technology investing across the United States, Europe, and Israel. The firm invests in areas including data and AI, semiconductors, cloud, quantum, and digital biology, and positions itself as providing both capital and operational support to founders. In healthcare and life sciences, its relevance is primarily through digital biology and healthtech-oriented portfolio companies rather than through operating its own therapeutic pipeline. Walden Catalyst was launched in 2021 and is associated with the investing legacy of Walden International and Samsung Catalyst Fund. It is a private, active investment management company rather than a drug developer, manufacturer, CRO, or therapeutic biotech.